These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2226595)

  • 1. Implications of insulin-like growth factors in renal cell carcinoma.
    Bennington JL; Strathearn M; Spencer EM; Williams RD
    Eur Urol; 1990; 18 Suppl 2():13-4. PubMed ID: 2226595
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin-like growth factors and recurrent hypoglycemia associated with renal cell carcinoma in a horse.
    Swain JM; Pirie RS; Hudson NP; Else RW; Evans H; McGorum BC
    J Vet Intern Med; 2005; 19(4):613-6. PubMed ID: 16095185
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of insulin-like growth factors and insulin-like growth factor I receptor expression in renal cell carcinoma.
    Schips L; Zigeuner R; Ratschek M; Rehak P; Rüschoff J; Langner C
    Am J Clin Pathol; 2004 Dec; 122(6):931-7. PubMed ID: 15539386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fas/APO-1 in renal cell carcinoma GRC-1 cell line during cell cycles.
    Li H; Yu L; Guo Y; Liang Y; Wang D
    Chin Med J (Engl); 1999 Nov; 112(11):1008-12. PubMed ID: 11721461
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of epidermal growth factor and insulin-like growth-factor I in renal carcinoma and adjacent normal kidney tissue.
    Pekonen F; Partanen S; Rutanen EM
    Int J Cancer; 1989 Jun; 43(6):1029-33. PubMed ID: 2543641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of erythropoietin by an established human renal carcinoma cell line: in vitro and in vivo studies.
    Shouval D; Sherwood JB
    Adv Exp Med Biol; 1988; 241():319-28. PubMed ID: 3223410
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta2 microglobulin: a surprising therapeutic target for prostate cancer and renal cell carcinoma.
    Freeman MR
    J Urol; 2007 Jul; 178(1):10-1. PubMed ID: 17574050
    [No Abstract]   [Full Text] [Related]  

  • 8. Interleukin-6 in renal cell carcinoma.
    Tsukamoto T; Kumamoto Y; Miyao N; Masumori N; Takahashi A; Yanase M
    J Urol; 1992 Dec; 148(6):1778-81; discussion 1781-2. PubMed ID: 1433606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of TGF-beta1 and MMP2 in human renal cell carcinoma and their clinical significance].
    Sun RC; Yang SD; Xu ZQ; Guo D; Mu HJ; Fan QH; Hu Q; Zhang LH; Liang JB
    Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):184-5. PubMed ID: 18788596
    [No Abstract]   [Full Text] [Related]  

  • 10. Messenger ribonucleic acids for fibroblast growth factors and their receptor in bladder and renal cell carcinoma cell lines.
    Yoshimura K; Eto H; Miyake H; Hara I; Arakawa S; Kamidono S
    Cancer Lett; 1996 May; 103(1):91-7. PubMed ID: 8616814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of growth factors in human renal cysts with or without renal cell carcinoma.
    Taide M; Kanda S; Eguchi J; Igawa T; Kanetake H; Saito Y
    Clin Chim Acta; 1993 Aug; 217(2):199-203. PubMed ID: 8261629
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heterogeneity of human renal cell carcinoma. III. 1 alpha,25-dihydroxyvitamin D3 receptor and inhibition on the growth of renal carcinoma cell lines].
    Nagakura K
    Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):92-7. PubMed ID: 3014194
    [No Abstract]   [Full Text] [Related]  

  • 13. Secretion of autocrine growth-promoting activity by renal-carcinoma cells treated with 5-fluorouracil.
    Nishimura N; Kanda S; Yogi Y; Kawamura M; Nakamura M; Hyakutake H; Kanetake H; Saito Y
    Int J Cancer; 1992 Aug; 52(1):105-9. PubMed ID: 1500215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor protein in human renal cell carcinoma.
    Turner K
    BJU Int; 2004 Sep; 94(4):678. PubMed ID: 15329141
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical perspectives of metabolomics: the example of renal carcinoma].
    Dormoy V; Massfelder T
    Med Sci (Paris); 2013 May; 29(5):463-8. PubMed ID: 23732093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Elaboration of erythropoietin in cultured cells].
    Tazaki H
    Hum Cell; 1988 Dec; 1(4):375-81. PubMed ID: 3154021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From genes to metabolomics in renal cell carcinoma translational research.
    Mulders PF
    Eur Urol; 2013 Feb; 63(2):252-3. PubMed ID: 23182551
    [No Abstract]   [Full Text] [Related]  

  • 18. αB-Crystallin and its emerging role in tumor progression and growth in systemic malignancies.
    Kapoor S
    Urol Oncol; 2013 Aug; 31(6):949. PubMed ID: 23886036
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: microRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
    Kapoor S
    Int J Urol; 2013 Jul; 20(7):739. PubMed ID: 23186135
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of lectins on 3H-uridine and 3H-thymidine uptake by cultured renal cell carcinoma and normal renal cells.
    Bazeed MA; Becht E; Schärfe T; Schmidt J; Jacobi GH; Thüroff JW
    Eur Urol; 1986; 12(2):117-22. PubMed ID: 3754210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.